FIELD: medicine.
SUBSTANCE: DNA is isolated from patient's peripheral venous blood, data about genetic polymorphism - 308G/A of tumor necrosis factor-α are obtained. In case if allele-308 A is identified, patients with genital endometriosis have high risk of development of endometrium hyperplasia.
EFFECT: application of the method makes it possible to predict risk of endometrium hyperplasia development in patients with genital endometriosis and on its basis to determine further tactics of management of patients with genital endometriosis.
1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING BENIGN MAMMRY DYSPLASIA IN FEMALES WITH GENITAL ENDOMETRIOSIS | 2012 |
|
RU2480763C1 |
METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH NORMAL BODY WEIGHT | 2024 |
|
RU2834521C1 |
METHOD FOR PREDICTING RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA USING MOLECULAR GENETIC DATA | 2024 |
|
RU2834523C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING ENDOMETRIAL HYPERPLASIA IN WOMEN WITH OVERWEIGHT OR OBESITY | 2024 |
|
RU2834146C1 |
METHOD FOR FORECASTING THE RISK OF DEVELOPMENT OF COMBINATION OF GENITAL ENDOMETRIOSIS AND HYPERPLASTIC ENDOMETRY PROCESSES BASED ON MOLECULAR-GENETIC DATA | 2018 |
|
RU2679637C1 |
METHOD FOR EVALUATING RISK OF ENDOMETRIAL CANCER | 2014 |
|
RU2558059C1 |
METHOD FOR PREDICTION OF ENDOMETRIAL HYPERPLASIA IN PATIENTS WITH HYSTEROMYOMA FOLLOWING UTERINE ARTERY EMBOLISATION | 2014 |
|
RU2558052C1 |
METHOD FOR PREDICTING RISK OF ENDOMETRIAL HYPERPLASTIC PROCESSES BASED ON GENETIC DATA | 2017 |
|
RU2650988C1 |
METHOD OF PREDICTING DEVELOPMENT OF RISK OF COMBINED PROLIFERATIVE REPRODUCTIVE SYSTEM DISEASES IN WOMEN | 2014 |
|
RU2557954C1 |
Authors
Dates
2012-11-27—Published
2011-08-12—Filed